Medical Device News Magazine

IQAir Introduces New XE Smart Air Purifiers

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

IQAir, a Swiss air quality technology company, launches their new XE air purifiers, the next generation of their best-selling high-performance air purifiers, in North America.

IQAir XE air purifiers feature a redesigned fan system that is up to three times more energy efficient than previous models. With Wi-Fi smart app integration, the air purifiers can be remotely controlled and fully integrated with IQAir’s AirVisual air quality app and platform. The XEs also include three smart modes, allowing for sensor-based operation and prompting automatic adjustment of the air purifier performance based on measured air quality.

Designed and made in Switzerland, the XE line also includes an advanced particle sensor that measures harmful fine particulate pollutants (PM2.5), for real-time insight of indoor air. PM2.5 includes a wide range of pollutants, including smoke, dust, pollen, mold spores, house dust mites, and pet allergens. The HealthPro XE utilizes IQAir’s patented HyperHEPA filtration, which captures over 99.5% of harmful ultrafine pollution particles and biological contaminants down to 0.003 microns in size. This includes particulate matter equal in size of bacteria and viruses such as those that cause COVID-19, the flu, and even the common cold.

Frank Hammes, Global CEO, IQAir.

“The XE line pairs the newest air quality monitoring technology with our award-winning, ultra efficient filtration. Built-in air quality sensors allow the system to automatically adjust filtration according to indoor air quality. This saves energy, extends filter life, and fully automates the removal of even the smallest particles from the air.”

For the North American market, the enhanced features of the XE air purifiers are incorporated into four of IQAir’s popular air purifiers and are now available on iqair.com/us/:

  • HealthPro Plus XE is priced at $1,199
  • HealthPro Compact XE is priced at $1,099
  • GC MultiGas XE is priced at $1,599
  • GCX MultiGas XE is priced at $2,499
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”